Viewing data from:

FORMOTEROL FUMARATE

ANDA

FORMOTEROL FUMARATE | A091141 | TEVA PHARMACEUTICALS USA INC

1 strength0 unique patents0 unique exclusivities

Reference Listed Drug: PERFOROMIST(TE code: AN)

Medicare Part D Spending

CMS annual spending data for Formoterol Fumarate (2023)

Total Spending

$6.4M

Total Claims

12,748

Beneficiaries

3,044

Avg Cost/Unit

$6.38

Spending Trend

$1.8M(2021)→$4.6M(2022)→$6.4M(2023)

YoY Change:-2.5%

5yr CAGR:-9.2%

Source: CMS Medicare Part D Spending by Drug (2023). Shows gross drug cost under Part D.

API Supply Chain13 active DMFs4 inactive

13 active API suppliers hold Drug Master Files for this ingredient.

INKE SAFORMOTEROL FUMARATE

DMF 166282003

MATRIX PHARMACORP PRIVATE LTDFORMOTEROL FUMARATE DIHYDRATE USP

DMF 192022006

CIPLA LTDFORMOTEROL FUMARATE USP

DMF 201782007

INDUSTRIALE CHIMICA SRLFORMOTEROL FUMARATE DIHYDRATE USP

DMF 201992007

TAPI NL BVFORMOTEROL FUMARATE DIHYDRATE

DMF 213572008

LUSOCHIMICA SPAFORMOTEROL FUMARATE DIHYDRATE

DMF 238482010

MSN LABORATORIES PRIVATE LTDFORMOTEROL FUMARATE USP [ROUTE CODE "FL"]

DMF 280112014

CORAL DRUGS PRIVATE LTDFORMOTEROL FUMARATE DIHYDRATE

DMF 303242016

FARMABIOS SPAFORMOTEROL FUMARATE

DMF 329362018

AMPHASTAR NANJING PHARMACEUTICALS INCFORMOTEROL FUMARATE USP

DMF 339132019

FERMION OYFORMOTEROL FUMARATE

DMF 338942019

MELODY HEALTHCARE PVT LTDFORMOTEROL FUMARATE

DMF 413172025

VAMSI LABS LTDFORMOTEROL FUMARATE DIHYDRATE USP

DMF 428102025

ASTELLAS PHARMA INCInactiveFORMOTEROL FUMARATE

DMF 123801997

INDUSTRIALE CHIMICA SRLInactiveFORMOTEROL FUMARATE DIHYDRATE MICRONIZED

DMF 141541999

SICOR SWISS BRANCHInactiveFORMOTEROL FUMARATE

DMF 162412002

VAMSI LABS LTDInactiveFORMOTEROL FUMARATE DIHYDRATE EP

DMF 404502024

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Jul 7, 2021	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (1)

#001 — 0.02MG/2ML

0 patents0 exclusivities▴

SOLUTION;INHALATION | Approved: Jun 22, 2021

No patent or exclusivity listings for this strength.